info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Celiac Disease Treatment Market: Rising Prevalence of Diabetes and Celiac Disease is Projected to Boost the Market Growth at a Healthy CAGR of 11.03% During the Forecast Period of 2022 to 2030

Pune, India, October 2022, MRFR Press Release/- Market Research Future has published a Half-Cooked Research Report on the Global Celiac Disease Treatment Market.


Market Highlights


According to MRFR analysis, Celiac Disease Treatment Market is anticipated to have a significant growth with a 11.03% CAGR. Therefore, the market value will further increase up to USD 1.28 Billion in the studied forecast period 2023-2033.


Celiac disease is a digestive disorder hindering the functioning of the small intestine. Celiac disease is triggered by eating foods containing gluten and is common among patients of down syndrome, Turner syndrome, and type 1 diabetes.


Rising diabetes cases, increasing prevalence of the celiac disease, favorable government policies across the Western world (the Americas and Europe), increasing number of clinical trials, raising awareness for the disease, and increasing penetration of therapeutic products in the developing economies are some of the major drivers for the global celiac disease treatment market.


However, factors such as limited availability of the treatment options and underdiagnosis/misdiagnosis of celiac disease are projected to restrain the market growth during the forecast period of 2019 to 2025.


Several market players currently dominate the global celiac disease treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.Explore In-depth Details: Celiac Disease Treatment Market Research Report


Regional Analysis


The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the increasing prevalence of celiac disease and rising per capita healthcare expenditure. On a regional basis, America's celiac disease treatment market has been further segmented into North America and Latin America. The North American market is further divided into the US and Canada. The European celiac disease treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The celiac disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing patient pool for diabetes and celiac disease, rapidly developing healthcare sector, and rising per capita healthcare sector enables the Asia-Pacific region to be the fastest-growing regional market for celiac treatment during the forecast period. The celiac disease treatment market in the Middle East & Africa has been divided into the Middle East and Africa.


Segmentation


The global celiac disease treatment market has been segmented based on treatment and end-user.


The market, based on treatment, has been divided into a gluten-free diet, vitamin & mineral supplements, enzyme supplement therapy, and medications. The gluten-free diet segment has been further segmented into gluten-free bakery products, gluten-free baby food, gluten-free pasta, and gluten-free meals. The medication segment is further divided into azathioprine and budesonide. The gluten-free diet segment held the largest market share in the market in 2018.


Based on end-user, the celiac disease treatment has been divided into hospitals & clinics, clinical research organizations, and research & academic institutes. Hospitals and clinics were the largest revenue shareholder in the global celiac disease treatment market.


Key Players


Some of the key players in the global celiac disease treatment market are Amgen Inc. (US), Amneal Pharmaceuticals LLC (US), BioLineRx (Israel), Calypso Biotech SA (Switzerland), Freedom Foods Group Limited (Australia), General Mills, Inc. (US), Glenmark Pharmaceuticals Inc. (India), Hain Celestial Group, Inc. (US), Innovate Biopharmaceuticals Inc. (US), Kellogg Company (US), Mondelez International Inc. (US), Mylan Pharmaceuticals Inc. (US), Pinnacle Foods, Inc. (US), Selecta Biosciences, Inc (US), Takeda Pharmaceutical Company Ltd (Japan), The Kraft Heinz Company (US), West-Ward Pharmaceutical (US), Zedira GmbH (Germany), Zydus Pharmaceuticals Inc. (US), and others.


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Base Year 2022
Companies Covered 15
Pages 110
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.